Director sold ~$198K of Exelixis
Scheduled in advanceTraded May 18, 2026 · Filed May 19, 2026
Exelixis's SVP and General Counsel sold $333K of Exelixis shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$332,641
Shares × reported transaction price
13 days after results of May 5, 2026, 79 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.3% | +1.2% | −1.0% |
| 30 days | +2.9% | +0.4% | +2.5% |
| 90 days | +6.5% | +3.5% | +2.9% |
Past results only. Not a forecast.
Director sold ~$198K of Exelixis
Scheduled in advanceDirector sold ~$492K of Exelixis
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.